MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 49 filers reported holding MILESTONE PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,038,711 | +21.5% | 335,068 | +11.7% | 0.29% | -2.3% |
| Q2 2023 | $855,194 | +8.9% | 300,068 | +50.5% | 0.30% | +15.4% |
| Q1 2023 | $785,565 | +98.4% | 199,382 | +99.4% | 0.26% | +67.1% |
| Q4 2022 | $396,000 | -68.6% | 100,000 | -27.1% | 0.16% | -56.0% |
| Q3 2022 | $1,261,000 | – | 137,200 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management III, LLC | 2,066,529 | $38,541,000 | 23.79% |
| Novo Holdings A/S | 2,674,470 | $49,879,000 | 8.54% |
| ACUTA CAPITAL PARTNERS, LLC | 369,500 | $6,891,000 | 4.97% |
| RTW INVESTMENTS, LP | 3,521,856 | $63,819,000 | 3.80% |
| Boxer Capital, LLC | 1,102,194 | $20,556,000 | 1.49% |
| Ghost Tree Capital, LLC | 235,000 | $4,383,000 | 1.12% |
| VHCP Management II, LLC | 148,560 | $2,771,000 | 1.06% |
| Tekla Capital Management LLC | 46,940 | $812,000 | 0.04% |
| Baker Brothers Advisors | 266,667 | $4,973,000 | 0.03% |
| Zimmer Partners, LP | 160,000 | $2,984,000 | 0.03% |